Fascination About timcodar
Individuals need to have totally recovered in the acute harmful outcomes of all prior anti-cancer therapy and need to meet the subsequent least length from prior anti-cancer directed therapy ahead of enrollment.Experimental: Dose expansion_sub-populace 2_higher dose of niraparib MTDs and/or candidate RP2Ds for elimusertib applied together with nira